LENZ THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-31.9M | $-41.5M | $-16.7M | $-14.9M | $-14.6M | $-10.2M | $-10.3M | $-16.6M |
| Depreciation & Amortization | — | $111.0K | — | — | $36.0K | — | — | $5.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $4.3M | — | — | $2.6M | — | — | $947.0K |
| Net Cash from Operating Activities | $-38.7M | $-33.6M | $-8.6M | $-11.5M | $-16.0M | $-10.6M | $-15.8M | $-23.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $16.0K | $18.0K | $439.0K | $240.0K | $110.0K | $186.0K | $133.0K | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $33.2M | — | — | $18.9M | — | — | $18.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $14.0K | — | — | $44.0K | — | — | $171.3M |
| Net Change in Cash | — | $-407.0K | — | — | $2.9M | — | — | $165.3M |
| Free Cash Flow | $-38.7M | $-33.6M | $-9.0M | $-11.7M | $-16.2M | $-10.8M | $-15.9M | $-23.9M |